-Bloomberg
BioCryst Selects Swixx BioPharma As Commercial Partner For ORLADEYO In Central And Eastern Europe
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced the company has entered into a collaboration with Swixx BioPharma AG to commercialize ORLADEYO® (berotralstat) in Central and Eastern Europe